Iradimed (IRMD) Retained Earnings (2013 - 2026)

Iradimed (IRMD) has 14 years of Retained Earnings data on file, last reported at $67.5 million in Q1 2026.

• Retained Earnings for Q1 2026 came in at $67.5 million, up 13.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.5 million (up 13.78% YoY), and the FY2025 annual result was $64.2 million, up 13.1% from the prior year.
• Retained Earnings improved to $67.5 million in Q1 2026 per IRMD's latest filing, from $64.2 million in the prior quarter.
• Over five years, Retained Earnings peaked at $67.5 million in Q1 2026 and troughed at $6127.0 in Q1 2022.
• A 5-year average of $48.7 million and a median of $47.4 million in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 80.98% in 2022, then soared 611087.2% in 2023.
• A 5-year view of Retained Earnings shows it stood at $47.3 million in 2022, then retreated by 8.48% to $43.3 million in 2023, then jumped by 31.28% to $56.8 million in 2024, then rose by 13.1% to $64.2 million in 2025, then rose by 5.08% to $67.5 million in 2026.
• Business Quant data shows IRMD's Retained Earnings at $67.5 million in Q1 2026, $64.2 million in Q4 2025, and $66.3 million in Q3 2025.